- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-09-0042758

Astorion Pharmaceuticals Private Limited
About Astorion Pharmaceuticals Private Limited
Data last updated:
Astorion Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC075940. Its GSTIN is 36AAJCA7865R1ZO (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Koyalkar Arun Kumar and Koyelkar Jyoshna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.121 W/P Judges Colony Mansoorabad Saroornagar, Hyderabad, Telangana, India – 500068.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.87 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹3.56 Lakh (net margin 1.9%) and EBITDA of ₹22.89 Lakh (EBITDA margin 12.3%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 13% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Astorion Pharma.
Astorion Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0042758). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Astorion Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2011PTC075940. The current CIN is U24232TG2011PTC075940, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC075940 | Current |
| U24232AP2011PTC075940 | Previous |
Recognitions & Rankings of Astorion Pharmaceuticals
Contact details
Astorion Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.121 W/P Judges Colony Mansoorabad Saroornagar, Hyderabad, Telangana, India – 500068
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Astorion Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Astorion Pharmaceuticals operates one associated brand: Astorion Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company specializing in diabetes and related health products in India. | astorionpharma.com |
Business activity
The main business activity of Astorion Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Astorion Pharmaceuticals Private Limited, buy the company report.
Financials of Astorion Pharmaceuticals Private Limited
FY 2025 filings availableAstorion Pharmaceuticals Private Limited reported revenue of ₹1.87 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 16% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.3% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astorion Pharmaceuticals Private Limited, buy the company report.
Board of directors of Astorion Pharmaceuticals Private Limited
Astorion Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Koyalkar Arun Kumar | Director | 12 Aug 2011 | 15 Years 2 Months | Current |
| Koyelkar Jyoshna | Director | 12 Aug 2011 | 15 Years 2 Months | Current |
Peer comparison
Astorion Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Frankfurt Pharmaceuticals Private Limited | ₹1.87 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India | |||
| Uniprogen Biotech Private Limited | ₹1.87 Cr (FY 2020) | -30.0% | Navi Mumbai, Maharashtra, India | |||
| Mo Medicine (OPC) Private Limited | ₹1.87 Cr (FY 2025) | 80.0% | Bhubaneswar, Odisha, India | |||
| Astorion Pharmaceuticals Private Limitedthis company | ₹1.87 Cr (FY 2025) | ₹3.56 Lakh | 1.9% | 16.0% | 6 | Hyderabad, Telangana, India |
| Leewell Pharmaceuticals Private Limited | ₹1.86 Cr (FY 2025) | 94.0% | Hyderabad, Telangana, India | |||
| Uas Pharmaceuticals (India) Private Limited | ₹1.86 Cr (FY 2019) | 0.0% | New Delhi, Delhi, India | |||
| Rose Pharmaco Pvt Ltd | ₹1.86 Cr (FY 2024) | 20.0% | Guwahati, Assam, India |
To see the full peer comparison of Astorion Pharmaceuticals Private Limited, buy the company report.
Auditor
Astorion Pharmaceuticals Private Limited is audited by SRIKALYAN & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SRIKALYAN & ASSOCIATES | FY 2020 | 013497S |
Shareholding
The shareholding of Astorion Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Astorion Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Astorion Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Astorion Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Astorion Pharmaceuticals Private Limited has a workforce of 6 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Astorion Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCA7865R1ZO | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Astorion Pharmaceuticals Private Limited, buy the company report.
Recent activity
Astorion Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Koyalkar Arun Kumar was appointed as Director on 12 Aug 2011.
Frequently asked questions
Astorion Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 August 2011 (15+ years old) and is registered under CIN U24232TG2011PTC075940.
Astorion Pharmaceuticals has 2 current directors:
- Koyalkar Arun Kumar - Director
- Koyelkar Jyoshna - Director
The latest financial statements of Astorion Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Astorion Pharmaceuticals is 36AAJCA7865R1ZO, registered in Telangana.
The CIN (Corporate Identification Number) of Astorion Pharmaceuticals is U24232TG2011PTC075940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astorion Pharmaceuticals was incorporated on 12 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Astorion Pharmaceuticals by revenue are Frankfurt Pharmaceuticals Private Limited, Uniprogen Biotech Private Limited, Mo Medicine (OPC) Private Limited, Leewell Pharmaceuticals Private Limited, Uas Pharmaceuticals (India) Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Koyalkar Arun Kumar was appointed as Director on 12 Aug 2011. Koyelkar Jyoshna was appointed as Director on 12 Aug 2011.
Yes, Astorion Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0042758).
The registered office of Astorion Pharmaceuticals is at Plot No.121 WP Judges Colony Mansoorabad Saroornagar, Hyderabad, Telangana, India – 500068.
Astorion Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.